Here, by performing a three-phase screen (Cox analysis, WGCNA analysis and differential expression analysis), we identified the APOL3 as a novel CRC-related ferroptotic marker and a modulator for CD8+ T cell infiltration. The gene discussed is CD8A; the disease is colorectal carcinoma.